Search - tctmd.com

Displaying 681 - 700 of 769

Sort: Relevancy | Date

News Industry News

Boston Scientific Announces Positive Data From Lotus™ Transcatheter Aortic Valve Trial

May 15, 2012

News Daily News

Local Anesthesia Feasible, Safe in Transfemoral TAVR

May 11, 2012

News Daily News

La Anestesia Local es Viable y Segura en la TAVR Transfemoral

May 11, 2012

News Daily News

CMS Agrees to Cover TAVR for FDA-Approved Use

Caitlin E. Cox

May 07, 2012

News Daily News

French Registry Provides Window into Real-World TAVR Use

Caitlin E. Cox

May 03, 2012

News Daily News

TAVR Suitable Even in Patients with Impaired LVEF

Caitlin E. Cox

April 19, 2012

News Industry News

FDA Panel Scheduled to Review Edwards SAPIEN Valve for High-Risk Patients on June 13

April 09, 2012

News Conference News ACC 2012

Study Looks at Long-term Mortality Predictors in TAVR Patients

Jason Kahn

March 27, 2012

News Conference News ACC 2012

PARTNER: TAVR Remains as Effective as Surgery at 2 Years

March 26, 2012

News Conference News ACC 2012

ADVANCE: TAVR with CoreValve Safe, Effective at 6 Months

March 24, 2012

News Daily News

PCI with Concomitant Aortic Stenosis May Not Increase Short-term Mortality

L.A. McKeown

March 23, 2012

News Daily News

Modified Transapical TAVR Technique Minimizes Paravalvular Regurgitation

March 23, 2012

News Daily News

La PCI con Estenosis Aórtica Concomitante podrían No aumentar la Mortalidad a Corto Plazo

L.A. McKeown

March 23, 2012

News Daily News

Hemodynamic Index Helps Define Impact of Aortic Regurgitation After TAVR

March 21, 2012

News Daily News

TCTMD’s Top 10 Most Popular News Stories From 2011

Jason Kahn

March 08, 2012

News Daily News

Experts Give Their Picks for Most Important Developments of 2011

Jason Kahn

March 08, 2012

News Daily News

Study Suggests 30-Case ‘Proficiency’ Threshold for TAVR

Yael L. Maxwell

March 06, 2012

News Daily News

Societies Recommend TAVR Program Requirements

L.A. McKeown

March 06, 2012

News Daily News

Patient Selection Trends Younger, Less High Risk for Transcatheter Valve Therapy

March 06, 2012

News Daily News

Registry Study: One-Year Outcomes Similar for TAVR, Surgery

L.A. McKeown

March 04, 2012

Advertisement

Boston Scientific Announces Positive Data From Lotus™ Transcatheter Aortic Valve Trial

Local Anesthesia Feasible, Safe in Transfemoral TAVR

La Anestesia Local es Viable y Segura en la TAVR Transfemoral

CMS Agrees to Cover TAVR for FDA-Approved Use

French Registry Provides Window into Real-World TAVR Use

TAVR Suitable Even in Patients with Impaired LVEF

FDA Panel Scheduled to Review Edwards SAPIEN Valve for High-Risk Patients on June 13

Study Looks at Long-term Mortality Predictors in TAVR Patients

PARTNER: TAVR Remains as Effective as Surgery at 2 Years

ADVANCE: TAVR with CoreValve Safe, Effective at 6 Months

PCI with Concomitant Aortic Stenosis May Not Increase Short-term Mortality

Modified Transapical TAVR Technique Minimizes Paravalvular Regurgitation

La PCI con Estenosis Aórtica Concomitante podrían No aumentar la Mortalidad a Corto Plazo

Hemodynamic Index Helps Define Impact of Aortic Regurgitation After TAVR

TCTMD’s Top 10 Most Popular News Stories From 2011

Experts Give Their Picks for Most Important Developments of 2011

Study Suggests 30-Case ‘Proficiency’ Threshold for TAVR

Societies Recommend TAVR Program Requirements

Patient Selection Trends Younger, Less High Risk for Transcatheter Valve Therapy

Registry Study: One-Year Outcomes Similar for TAVR, Surgery

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content